“ASSESSMENT OF INJECTION SITE REACTION IN PATIENTS TREATED WITH BIOLOGIC DRUGS FOR SUBCUTANEOUS ADMINISTRATION” (2022) Journal of Pharmaceutical Negative Results, 13(3), pp. 523–528. doi:10.47750/pnr.2022.13.03.080.